Alumis, Inc. (ALMS)
6.85
-0.36
(-4.99%)
USD |
NASDAQ |
Oct 02, 16:00
6.845
0.00 (0.00%)
After-Hours: 20:00
Alumis Gross Profit Margin (Quarterly) : 47.41% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 47.41% |
| March 31, 2026 | 49.97% |
| December 31, 2025 | 55.05% |
| Date | Value |
|---|---|
| September 30, 2025 | 55.66% |
| June 30, 2025 | 67.37% |
| March 31, 2025 | 95.15% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Johnson & Johnson | 68.73% |
| Corcept Therapeutics, Inc. | 98.41% |
| Aclaris Therapeutics, Inc. | 10.80% |
| BioAge Labs, Inc. | 97.14% |
| ANI Pharmaceuticals, Inc. | 54.97% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -100.2% |
| Return on Assets | -79.89% |
| Return on Invested Capital | -92.37% |
| Profit Margin (Quarterly) | -8.56K% |
| Operating Margin (Quarterly) | -6.44K% |
| Return on Net Operating Assets | -497.6% |